China Healthcare

China Healthcare
  • Pininvest Analysis

No one doubts health care in China is becoming an ever bigger story and no one will be surprised to see the Chinese authorities focus doggedly on strengthening the country’s pharmaceutical expertise

With most of the pharmaceutical businesses quoted on Chinese stock markets, American investors may be advised to refer to our theme of US listed companies as informative – but partial – guidelines regarding some of the Chinese health care trends

  • Not all the OTC-listed companies appear to be actively traded, though successfully introduced on the Chinese market
  • High valuations may in many cases reflect a tendency of the Chinese investors to ‘overshoot’ in a spurt of optimism

The overall growth perspectives, and the will to ensure Chinese companies are the immediate beneficiaries, are unquestionable – foreign providers, such as Novo Nordisk of Denmark [asset ticker="NVO" mnemonic="NYSE"] in the diabetes market, are well aware of the challenge

Read our notes

China Healthcare • Updated:

Name Ticker Exchange Sector Industry Currency Cur.Price Mkt.Cap Perf. Momentum Vol. Risk Contrib. MDD
 
Alibaba Health Information Technology ALBHF OTC Health Care Healthcare Supply Chain & InfoTech USD 1.70 - -37.0 % Sharp Down 63 %   10 % -65 %
BeiGene BGNE NASDAQ Health Care Gene Editing - Cell Therapies USD 316.59 29 B 51.5 % Weak Down 53 %   8 % -30 %
Cellular Biomedicine CBMG NASDAQ Health Care Biopharmaceuticals USD 19.75 384 M 50.0 % Weak Up 35 %   1 % -11 %
Concord Medical Services CCM NYSE Health Care Healthcare Facilities & Services USD 2.98 129 M 67.4 % Neutral 140 %   17 % -54 %
CSPC Pharmaceutical Group CHJTF OTC Health Care Drug Manufacturers - Diversified USD 1.42 - 11.3 % Strong Up 75 %   3 % -49 %
Genscript Biotech GNNSF OTC Health Care Biopharmaceuticals USD 4.35 - 97.9 % Weak Down 86 %   8 % -34 %
Guangzhou Baiyunshan Pharmaceutical Holdings GZPHF OTC Health Care Drug Manufacturers - Diversified USD 3.14 - -14.0 % Strong Up 30 %   1 % -34 %
Hutchison China MediTech HCM NASDAQ Health Care Drug Manufacturers -Specialty Pharma USD 42.05 6.1 B 55.1 % Strong Up 53 %   6 % -36 %
Novo Nordisk NVO NYSE Health Care Diabetes USD 92.60 218 B 42.5 % Strong Up 22 %   2 % -13 %
Shandong Weigao Group Medical SHWGY OTC Health Care Medical Consumables & Intermediates USD 7.35 - -22.1 % Sharp Down 48 %   5 % -41 %
Shanghai Fosun Pharmaceutical SFOSF OTC Health Care Drug Manufacturers - Diversified USD 7.83 - 67.7 % Neutral 64 %   6 % -17 %
Shanghai Pharmaceuticals SHPMY OTC Health Care Drug Manufacturers - Diversified USD 10.51 - 18.1 % Neutral 49 %   3 % -28 %
Sino Biopharmaceutical SBMFF OTC Health Care Drug Manufacturers - Diversified USD 0.83 - -34.2 % Sharp Down 54 %   4 % -37 %
Sinopharm Group SHTDF OTC Health Care Drug Manufacturers - Diversified USD 2.65 - 8.2 % Sharp Down 46 %   4 % -25 %
Tong Ren Tang Technologies TGRNF OTC Health Care Drug Manufacturers - Diversified USD 0.62 - -22.5 % Neutral 29 %   1 % -26 %
WuXi Biologics (Cayman) WXXWY OTC Health Care Medical Laboratories & Research USD 31.32 - 128.7 % Weak Down 89 %   13 % -53 %
Zai Lab ZLAB NASDAQ Health Care Oncology USD 144.61 13 B 90.0 % Weak Down 63 %   10 % -39 %